CClinicalTrials.gg
SuspendedNCT02156219Updated Jul 26, 2017

Impact Evaluation of Separating Women and Men in the Metro of Mexico City

An observational study in Violence Against Women (VAW), sponsored by Econometría Consultores. Suspended at 1 site in Colombia. Open to female participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2017-07-26.

Sponsored by Econometría Consultores · Observational

Why this study was suspended
The STC has had financial limitations to start implementing the intervention.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
2,360
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

The purpose of this study is to determine whether the separation of men and women in the metro of Mexico City leads to an improvement in the violence and perception of violence towards women.

Read the detailed description

The purpose of this study is to determine whether the separation of men and women in the metro of Mexico City leads to an improvement in the violence and perception of violence towards women.

The separation of men and women will take place in the Line 5 of the metro system. The separation will operate between 6:00am-10:00am and 2:00pm and 10:30pm. Line 4 and 6 will be used to estimate the counterfactual.

Women eligible to participate in the study will be those aged 18 and 65 years who use lines 4, 5, and 6 between 7am and 9am or between 11am and 1pm before the separation between men and women is implemented. Eligible women must reside in Mexico City or the metropolitan area of the Valley of Mexico (60 municipalities agglomerates in the State of Hidalgo and Mexico State).

Women will be recruited in the metro before the separation between men and women is implemented. They will be asked for their name, e-mail and telephone number. Also before the separation is implemented, they will be asked to answer a telephone survey to collect baseline information. The same women will be contacted again in the following 12 to 15 months to collect the endline survey, also by phone. The implementation of the separation will take place after the baseline survey has been collected.

02

Conditions studied

  • Violence Against Women (VAW)
03

In context

Lead sponsor

Econometría Consultores is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Women aged 18-65 who reside in Mexico City or the metropolitan area of the Valley of Mexico and that are users on the Metro lines 4, 5 and 6 between 7 and 9 or 11 and 1pm at baseline

Inclusion criteria

  • Women aged 18-65 who reside in Mexico City or the metropolitan area of the Valley of Mexico and that are users on the Metro lines 4, 5 and 6 between 7 and 9 or 11 and 1pm at baseline

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
2,360 participants (estimated)
Patient registry
No

Groups and cohorts

  • Under separation

    Exposure to the separation of women and men in the metro of Mexico City.

    Other: Separation of women and men in the metro of Mexico City

  • No treatment

    Non exposure to the separation of women and men in the metro of Mexico City.

Interventions

  • OtherSeparation of women and men in the metro of Mexico City

    The measure of separation between men and women exists in all modes of public transport in Mexico City (metro, metro-bus, trolley, bus and light rail), although it is not 100% implemented on all lines and in all hours. These differences in implementation schedule can be a way to identify a treatment group and a control group, and the fact that it has not been implanted in all lines/paths will allow to have a baseline. The implementation of the measure of separation of men and women on the subway consists of three operational tasks: 1. Control: Surveillance that men do not use cars corresponding to women. 2. Dosage: Regulation of entry women. 3. Assignment: Of the women, to the part of the platform where the first wagons stop.

06

What researchers measure

Primary outcomes

  1. Perception of safety in public transport

    The outcome will be measure through a survey to women who use the lines 4, 5 and 6 of the metro system of Mexico City.

    Time frame: Average of 1 year since the start of the intervention

Secondary outcomes

  1. Events of Violence against women in public transport

    The outcome will be measure through a survey to women who use the lines 4, 5 and 6 of the metro system of Mexico City.

    Time frame: 6 months

  2. Behaviors, attitudes and perceptions of women about violence in public transport

    The outcome will be measure through a survey to women who use the lines 4, 5 and 6 of the metro system of Mexico City.

    Time frame: Average of 1 year since the start of the intervention

  3. Women's autonomy (economic performance, activities outside the home)

    The outcome will be measure through a survey to women who use the lines 4, 5 and 6 of the metro system of Mexico City.

    Time frame: Average of 1 years since the start of the intervention

  4. Negative externalities (perception of safety outside the public transport)

    The outcome will be measure through a survey to women who use the lines 4, 5 and 6 of the metro system of Mexico City.

    Time frame: 6 months

07

Study locations

1 site
  • Econometria Consultores
    Bogota, Colombia
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 26, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02156219
Lead sponsor
Econometría Consultores
Collaborators
Inter-American Development Bank
Responsible party
Sponsor
First posted
Jun 5, 2014
Start date
Jan 1, 2014
Primary completion
Dec 30, 2017 (estimated)
Completion
Dec 30, 2017 (estimated)
Last update
Jul 26, 2017

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is suspended, as verified in Feb 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion